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Abstract: Balsamin, a type I ribosome-inactivating protein (RIP), has been shown to inhibit 
HIV-1 replication at the translation step. Our recent studies have shown that balsamin also 
possess anti-tumor, antibacterial and DNase-like activity, however, the amount of natural 
balsamin in Momordica balsamina seeds is limited and preclinical studies require large 
quantities of pure, bioactive balsamin. Therefore, in this study, we cloned the balsamin gene, 
expressed it in E.coli BL21 (DE3) strain and purified it by nickel affinity chromatography. 
Functional analysis indicated that balsamin exhibits both RNA N-glycosidase activity, 
releasing the Endo-fragment from rabbit reticulocyte rRNA, and DNase-like activity, 
converting the supercoiled form of a plasmid into the linear form in a concentration-dependent 
manner. Analysis of secondary structure revealed that recombinant balsamin mainly consisted 
of α-helical and random coiled with minimal turns and β-sheets. Recombinant balsamin was 
found to be stable in the temperature range of 20-60 °C and pH range of 6-9. Antimicrobial 
assays showed that the minimum inhibitory concentrations of recombinant balsamin for 
various pathogens ranged between 1.56-12.5 µg/ml. Heterologous expression and purification 
of balsamin carries great importance as it provides an alternative approach for large-scale 
preparation of biologically active recombinant balsamin, which is difficult from its natural 
source. 
 






















Ribosome inactivating proteins (RIPs) are protein synthesis inhibitors that cleave the 
glycosidic linkage between adenine and ribose in a highly conserved SR (α-sarcin/ricin) loop 
in the 28S rRNA. This cleavage prevents binding of elongation factors during the translation 
process, thus inhibiting protein synthesis [1]. RIPs are widely distributed in plants including 
Momordica species. RIPs isolated from Momordica species have attracted growing interest for 
their role in viral and tumor growth inhibition. Moreover, their unique natural role of targeting 
the conserved host protein synthesis machinery makes them a potential tool in chemotherapy 
for cells that develop drug resistance [2-4]. Since RIPs bind to specific receptors on the surface 
of cancer cells, they pose minimal or no detectable adverse effects on normal cells, thus, 
increasing their potential as anticancer therapeutic agents [3,4,5]. Besides RNA N-glycosidase 
activity, RIPs exhibited polynucleotide adenosine glycosidase, antimicrobial, DNase, and 
broad-spectrum antiviral activities including against human immunodeficiency virus [6]. RIPs 
have been exploited in plant protection against various fungal, viral and bacterial pathogens 
and are therefore also known as antimicrobial proteins [7,8]. 
Balsamin isolated from Momordica balsamina is a type-I RIP that can inhibit HIV-1 
replication by targeting the translation step that occurs prior to HIV-1 budding and release [9]. 
Our recent studies have shown that balsamin also possesses DNase-like activity, inhibits the 
growth of bacterial pathogens and induces apoptosis in breast cancer cells [10, 11]; however, 
the amount of balsamin in M. balsamina seeds is limited. Moreover, recovery and purification 
of balsamin from natural sources involves multiple purification steps that compromises protein 
yield. Heterologous protein expression in a suitable recombinant strain offers an attractive 
alternative with higher yields, shorter fermentation time and cheaper production costs. 
Therefore, in this study the balsamin gene was cloned and expressed, and the biological 
functions of recombinant balsamin (rBalsamin) were investigated. 
Several RIP genes from Momordica species have been heterogeneously expressed. α-
momorcharin (α-MC) was the first gene to be cloned using a λgt11 cDNA library constructed 
from M. charantia seeds, followed by its mass production in a heterologous system, the E.coli 
Rosetta (DE3) pLysS strain [12,13]. The MAP30 gene was cloned in a pET-28 vector and 
expressed in E.coli BL21(DE3) cells [14]. In other studies, Momordica antiviral protein 
(MAP30) was fused with the human-derived cell penetrating peptide HBD to improve the 

















investigated various functional properties of balsamin [9-11]. However, to explore animal 
studies and clinical trials a large quantity of pure protein is required. Thus, in this study we 
attempted the heterologous expression of balsamin. 
Immobilized metal affinity chromatography (IMAC) has been widely used for large-scale 
purification of proteins linked to polyhistidine residues (His-tag) at the N- or C- terminus. 
IMAC provides high specificity and ease of purification [16]. The ability of histidine residues 
to bind to an immobilized metal ion matrix with high affinity under denaturing and native 
conditions has made the polyhistidine tag a powerful tool for protein purification [17]. The 
immobilization of a His-tag on an IMAC matrix is a rapid and inexpensive method used to 
study protein-protein interactions and to purify recombinant proteins with up to 95% purity 
[18]. 
Herein we report for the first time, heterologous expression of His-tagged rBalsamin in an 
E.coli expression system. Of all the expression systems, E.coli was used for this study because 
of its advantage over other host cells, namely fast growth kinetics, ease of transformation with 
exogenous DNA and low cost of rich complex growth media.  In this study, we describe an 
IMAC based method of obtaining a biologically active rBalsamin from an E.coli expression 
system. In addition, physicochemical parameters were optimised to obtain maximum 
expression of balsamin. Further, biophysical characterization of rBalsamin and its other 
functional properties were optimised.  
2. Materials and methods 
2.1  Enzymes, chemicals and purification kits 
Seeds of M. balsamina were procured from National Seed Stock (India). All chemicals 
used in this study were either obtained from Sigma-Aldrich (St. Louis, MO, USA) or Bio-Rad 
Laboratories (Hercules, CA, USA) and were of analytical grade. DNA ligase, Phusion DNA 
polymerase and DNA markers were from New England Biolabs Inc. (Ipswich, MA, USA). 
Precision PlusTM dual colour protein marker was from Bio-Rad Laboratories (Hercules, CA, 
USA). Restriction enzymes (BamHI and XhoI) and pET- 30a(+) were procured from Novagen 
Inc. (Wisconsin, USA). RNAqueous® Total RNA Isolation Kit was obtained from Life 
Technologies Corporation (California, USA). Plasmid DNA purification kit, QIAquick PCR 
purification kit and QIAquick gel extraction kit were from Qiagen Pty. Ltd. (Hilden, Germany). 
MasterPure™ DNA Purification Kit was from Epicentre (Wisconsin, USA). Immobilized 

















grade column were procured from GE Healthcare (Little Chalfont, UK). 
2.2  Bacterial strains 
E.coli DH10β and BL21(DE3) strains were obtained from New England Biolabs Inc. 
(Ipswich, MA, USA). Bacterial strains used for antimicrobial assay were procured from 
American Type Culture Collection (Virginia, USA).  
2.3  Molecular cloning of the gene encoding Balsamin  
The genomic DNA of M. balsamina seeds was isolated using a MasterPure™ DNA 
purification kit. To amplify the balsamin (Bal) gene from the genomic DNA, seven different 
degenerate PCR primers were designed based on published data [13,14,19-23]. The list of 
forward and reverse primers used in the study is given in Table 1. The PCR reaction was 
performed in 50 μl volume containing; 0.5 μg of genomic DNA as template, 0.5 μM each of 
forward and reverse primer, 250 μM dNTP, 1.5 mM MgCl2, 0.5 U Phusion DNA polymerase, 
and 1X Phusion HF buffer. The PCR procedure included: 98 °C for 2 min as initial 
denaturation, 35 cycles at 98 °C for 15 sec (denaturation), 65 °C for 30 sec (annealing), 72 °C 
for 60 sec (extension) and then 72 °C for 5 min as a final extension step. Finally, the PCR 
products were analyzed by electrophoresis on a 0.8% agarose gel.  
The gene fragments obtained after PCR were purified from the gel using a QIAquick gel 
extraction kit. The samples (prepared by mixing 1 μg DNA template; 0.5 μM forward primer; 
2.5 μl Milli Q water) were sent to Macrogen Inc., Seoul, Korea for sequencing. 
2.4  Construction of recombinant vector pET-Bal  
Specific sense and antisense primers were designed according to the nucleotide sequence 
of the balsamin: forward primer: 5’-CGGGATCCATGTTTATCAAAGC-3’; and reverse 
primer: 5’-CAGCTCGAGTTAGGAGCTGAAGCCT-3’. The highlighted bases in the forward 
and reverse primers were denoted as BamHI and XhoI restriction sites, respectively.  The PCR 
reaction mixture was performed in 50 μl volume containing; 0.5 μg of DNA fragment 
(sequenced), 0.5 μM each of specific forward and reverse primer, 250 μM dNTP, 1.5 mM 
MgCl2, 0.5 U Phusion DNA polymerase and 1X Phusion HF buffer. The PCR procedure 
included: 98 °C for 1 min (initial denaturation), 30 cycles at 98 °C for 10 sec, 64 °C for 20 sec, 

















The PCR amplified fragment (digested with BamHI and XhoI) was cloned into pGEM-T 
vector, digested with the same enzymes, and transformed into E.coli DH10β cells. The correct 
insertion of the Bal gene was confirmed by DNA sequencing (Macrogen, Inc., South Korea). 
The plasmid was double digested and subcloned between the BamHI and XhoI sites of the pET-
30a(+) vector. The recombinant vector thus generated was designated pET-Bal. The correct 
insertion of the Bal gene was confirmed by colony PCR with vector-specific primers and 
restriction digestion with BamHI and XhoI.  
2.5  Expression of rBalsamin in E.coli  
For bacterial expression of the gene encoding balsamin, pET-Bal was transformed into 
E.coli BL21(DE3) competent cells. A single colony harbouring the pET-Bal recombinant 
plasmid was inoculated into 20 ml of LB broth containing 50 μg/ml of kanamycin and grown 
overnight at 37 °C and 250 rpm. The next day, the overnight culture was inoculated into 500 
ml of LB broth containing 50 μg/ml of kanamycin at a ratio 1:100 and grown at 37 °C and 250 
rpm until an OD600nm of 0.4-0.6 was reached. Protein expression was induced by addition of 
isopropyl β-D-1-thiogalactopyranoside (IPTG). Culture parameters, such as growth 
temperature (20 °C, 25 °C, 30 °C and 37 °C), IPTG concentration (0.2, 0.4, 0.6, 0.8 and 1.0 
mM) and culture time (4, 8, 12, 16 and 20 h) were optimized for the production of rBalsamin. 
After induction, the cells were harvested by centrifugation at 12,000 X g for 20 min at 4 °C. 
The cell pellet was dissolved in lysis buffer (50 mM Tris-HCl buffer, pH 7.5, 300 mM NaCl 
and 20 mM imidazole) and the cells were disrupted using an ultra-sonicator (Vibra-Cell VCX 
500, Sonics, USA). Sonication was carried out for 15 min at 30% amplitude using a 3mm 
tapered micro tip probe. After sonication, the cells were centrifuged at 12,000 X g for 15 min 
at 4 °C. Samples of the soluble (supernatant) and insoluble (cell pellet) fractions were analysed 
by SDS-PAGE.  
The insoluble fraction obtained after centrifugation was dissolved in buffer A (50 mM 
Tris-HCl buffer, pH 7.5, 300 mM NaCl, 20 mM imidazole and 8M urea) and stirred at room 
temperature for 30 min for cell disruption. The suspension was then centrifuged at 12,000 X g 
for 20 min at 4 °C and then passed through a 0.22 µm filter. 
2.6  Purification of rBalsamin 
Immobilized metal affinity chromatography (IMAC) is a common technique used to purify 

















Sepharose 6 fast flow was used for purification. The cell free supernatant was applied to a Ni2+ 
Sepharose 6 fast flow column (10 X 1.5 cm) pre-equilibrated with buffer A. To remove the 
unbound protein, the column was washed with buffer A. To refold the bound protein on the 
column, the column was washed with a linear gradient of urea (8-0 M) in buffer A. Finally, the 
bound proteins were eluted from the column using buffer B (50 mM Tris-HCl buffer, pH 7.5, 
300 mM NaCl, and 250 mM imidazole). The protein content in each fraction was measured 
using the Bradford method and analysed on SDS-PAGE. Finally, the fractions were 
concentrated using an ultrafiltration membrane (Amicon Ultra-15, 10 kDa, US) and stored at -
80 °C. 
For further purification of rBalsamin, the concentrated fractions were applied to a Hi 
LoadTM 26/60 SuperdexTM 75 prepacked column pre-equilibrated with 50 mM Tris-HCl, pH 
7.5 (degassed). The protein was eluted with 50 mM Tris-HCl, pH 7.5 (degassed) at a flow rate 
of 0.5 ml min-1. The eluted fractions were analysed by SDS-PAGE for the presence of 
rBalsamin and the fractions containing the protein were concentrated by ultrafiltration, and 
stored in aliquots at -80 °C. 
2.7  rRNA N-glycosidase activity 
The assay was conducted as described by Kaur et al. [24]. Briefly, rabbit reticulocyte lysate 
was treated with rBalsamin for 30 min at 30 °C. After the treatment, the reaction was stopped 
by adding 10% SDS (w/v). Total rRNA was then extracted using RNAqueous® Total RNA 
Isolation Kit and aliquoted in two centrifuge tubes. One aliquot was treated with aniline acetate 
(pH 4.5) and the other one was left untreated. The samples were incubated at 60 °C for 3 min. 
The treated and untreated samples were analyzed on a 2% agarose gel and visualized using a 
Gel Doc™ XRS+ system (Bio-Rad, Hercules, CA, USA). 
2.8  Circular dichroism (CD) spectroscopy 
rBalsamin (450 μg/ml in 50 mM Tris-HCl buffer, pH 7.8) secondary structural information 
was derived from CD spectra obtained in the far UV range (190-260 nm) at a scanning speed 
of 100 nm/min using a temperature controlled Jasco J-815 CD spectrometer (Jasco Inc., Easton, 
MD, US). 
To study the effect of temperature on the secondary structure of rBalsamin the spectra were 
recorded over a temperature range from 20 to 90 °C with a heating rate of 1 °C/min. In addition, 

















were measured and analysed using Spectra managerTM software. 
2.9  Fluorescence spectroscopy 
The fluorescence scans of rBalsamin (100 μg/ml in 50 mM Tris-HCl buffer, pH 7.8) were 
recorded using a spectroflurometer with parameter set as: λexcitation = 280 nm (slit width 5 nm), 
λemission = 300-500 nm (slit width 5 nm), medium speed. 
To study the effect of temperature on the tertiary structure of rBalsamin, the fluorescence 
spectrum was measured over a temperature range of 20 to 90 °C with a heating rate of 1 °C/min. 
Further, to study the effect of pH, the emission scans of rBalsamin dissolved in buffer with pH 
ranging from 4-11 were recorded.  
2.10  Deoxyribonuclease (DNase)- like activity assay 
DNase-like activity of rBalsamin was determined as described by Ajji et al. [10]. pUC19 
plasmid (0.25 μg) was treated with various amounts of rBalsamin (0.5 μg, 1 μg, 1.5 μg or 2 μg) 
for 2 h at 37 °C in a final volume of 10 μl made with DNase buffer (50 mM Tris HCl, pH 7.5, 
50 mM KCl, 0.1 mM MgCl2). Untreated plasmid DNA and EcoRI treated plasmid DNA served 
as negative and positive controls, respectively. 
2.11  Antimicrobial activity of rBalsamin 
The antimicrobial activity of rBalsamin was determined by disc diffusion and broth 
microdilution methods, as described by Ajji et al. [10]. 
2.12  Antioxidant activity 
2.12.1 Determination of DPPH radical scavenging activity 
The activity was determined using 2, 2-Diphenyl-1-picrylhydrazyl (DPPH). For this, 40 μl 
of various concentrations of rBalsamin (0.1, 0.5, 1, 1.5, 2, 2.5 mg ml-1) were incubated with 
160 μl of 0.2 mM DPPH solution at room temperature for 30 min in the dark. After incubation, 
the absorbance of the samples was measured at 517 nm. The free radical scavenging activity 
of rBalsamin was then calculated using the formula: 

















2.12.2 Determination of superoxide radical scavenging activity 
The activity was determined using nitroblue tetrazolium (NBT) as previously described 
[10]. 
2.12.3 Evaluation of reducing power ability 
The reducing power of rBalsamin was determined according to Hong et al. [25]. Phosphate 
buffer and ascorbic acid were used as blank and positive controls, respectively. 
3. Results and discussion 
3.1  Cloning of Balsamin in E.coli 
Balsamin, a type I RIP, was isolated from the seeds of M. balsamina. This RIP has 
previously shown to possess anti-HIV, anti-breast cancer, antibacterial and DNase-like activity 
with a potential to be used in therapeutics [9-11]. In the present study, a Balsamin encoding 
gene, Bal, was isolated from the seeds of M. balsamina. Since most of the RIP genes are 
intronless, it was feasible to obtain an open reading frame (ORF) of the Bal gene from genomic 
DNA by PCR. Therefore, genomic DNA from the seeds of M. balsamina was extracted (Fig. 
S1) and used as a template for the amplification of the gene encoding balsamin. Among the 7 
degenerate primers used to amplify the Bal gene fragment, one primer resulted in the 
amplification of an ORF of the mature peptide (Fig. S2). The amplified gene (Fig. S3) was 
purified and sequenced. The sequencing results were confirmed by comparing the sequence 
with the nucleotide database using basic local alignment search tool (BLAST software, NCBI). 
A BLAST search of the sequenced gene showed 89% homology to α-MMC, a type-I RIP 
obtained from M. charantia (Fig. S4). 
The Bal gene was double digested and directionally subcloned between the BamHI and 
XhoI sites of the pET-30a(+) vector. The recombinant plasmid thus generated was designated 
as pET-Bal, and transformed into E.coli BL 21(DE3) competent cells. The correct insertion of 
Bal gene was confirmed by colony PCR with vector specific primers (Fig. S5A) and 




















3.2  Expression and purification of rBalsamin 
E.coli BL21-pET-Bal cells were cultured in LB broth containing 50 μg/ml kanamycin at 
37 °C, 250 rpm until the OD600 reached approximately 0.6. The expression of rBalsamin was 
then induced by IPTG. The recombinant bacterial cells were collected by centrifugation and 
disrupted by sonication. The expression and molecular weight of rBalsamin was assessed in 
the supernatant and cell pellet by 12% SDS-PAGE. A band at the expected size (~ 29 kDa) was 
observed in the cell pellet of the induced cells (Fig. 1, Lane 3, arrow). No band was visible at 
this position in the supernatant (Fig. 1, Lane 2) indicating that rBalsamin was expressed in the 
insoluble fraction and possibly got accumulated in inclusion bodies rather than the soluble 
fraction. Also, the absence of a protein band corresponding to the rBalamin in the uninduced 
cells (Fig. 1, Lane 1) indicated tight repression in the absence of IPTG and fine control of 
rBalsamin expression in the E.coli BL 21(DE3) system. To obtain a maximum yield of the 
rBalsamin, culture conditions such as temperature (20-37 °C), induction time (4-20 h) and 
IPTG concentration (0.2-1.0 mM) were optimised. It was observed that the optimum expression 
of insoluble rBalsamin was obtained at 30 °C (Fig. 2A) after 4 h (Fig. 2B) of induction with 
0.4 mM IPTG (Fig. 2C). 
The His-tagged rBalsamin was purified by a two-step purification strategy. rBalsamin was 
expressed in the insoluble fraction, therefore, the purification of rBalsamin was carried out in 
a Ni2+ Sepaharose 6 fast flow column under denaturing conditions (buffer containing 8M urea). 
The rBalsamin in the cell suspension was adsorbed to the Ni2+ Sepharose column. After the 
unadsorbed proteins were washed out, refolding of the bound protein was performed by the use 
of a linear gradient of urea (8-0 M) in the wash buffer. Finally, the rBalsamin was eluted from 
the column by increasing the concentration of imidazole to 250 mM in the elution buffer (with 
no urea). 10 μl of sample from each of the collected fractions was loaded on a 12% SDS-PAGE 
gel to assess the purity of the protein (Fig. 3, Lane 5 & 6). The fractions were pooled, 
concentrated (Fig. 3, Lane 7) and further purified by gel filtration chromatography using a 
Superdex 75 gel-filtration column. The column was washed with 50 mM Tris-HCl, pH 7.5 
(degassed) at a flow rate of 0.5 ml/min. Two peaks were obtained (Fig. 4) and analyzed using 
12% SDS-PAGE. The purified fraction PII was subsequently found to contain most of the 
protein of approximately 29 kDa, corresponding to the predicted molecular mass of rBalsamin 
(Fig. 3, Lane 8). These fractions were pooled and concentrated. The purity of the concentrated 
rBalsamin was confirmed by the presence of single band on the gel (Fig. 3, Lane 9). 

















purification procedure. A similar strategy has previously been employed for purification of 
other RIPs in E.coli strains. α-luffin, a type-I RIP, was expressed in E. coli BL21(DE3)pLysS 
strain and purified by Ni-nitrilotriacetic acid (NTA) agarose affinity chromatography. 
However, the final yield of soluble protein was reported to be 0.45 mg/l bacterial cell culture 
[20], 100 times lower compared to the protein yield in our study. α-MMC expressed in E.coli 
Rosetta (DE3)pLysS strain and purified by Ni- NTA agarose affinity chromatography produced 
85 mg/l of soluble α-MMC [13], around double the yield reported in our study. This difference 
might be due to the fact that rBalsamin was expressed in the insoluble fraction, which required 
additional purification and protein-refolding steps leading to reduced protein yield. 
3.3  rRNA N-glycosidase activity 
RNA N-glycosidase activity is a unique characteristic exhibited by RIPs that causes 
hydrolysis of the N-glycosidic bond at A-4324 in 28S rRNA resulting in the release of a 400 
bp fragment (the Endo-fragment) on aniline treatment. To confirm whether the purified 
rBalsamin was properly refolded during purification and is biologically active, an rRNA N-
glycosidase assay was performed. It was observed that the 28S rRNA generated a typical Endo 
fragment after treatment with rBalsamin. The rRNAs seemed stable towards rBalsamin without 
the treatment of aniline as no fragment appeared at this stage on a 0.8% agarose gel. Only after 
the treatment with aniline, the rRNA was cleaved resulting in generation of the Endo-fragment 
(Fig. 5). Native balsamin (nBalsamin) isolated from M. balsamina served as a positive control. 
These results were in accordance with RNA N-glycosidase activity of other RIPs reported from 
different plant species [26,27].  
3.4  Biophysical characterization of rBalsamin 
The secondary structure of rBalsamin expressed in the E.coli expression system was 
determined using CD spectroscopy. The CD spectrum of the rBalsamin in the far UV region 
indicated the presence of predominantly α-helices and random coils. rBalsamin exhibited 
34.8% α-helix, 19.3% β-sheet, 12.5% turn and 32.5% random coils at 25 °C, which were 
comparable to the CD profile reported for nBalsamin purified from M. balsamina [24]. Some 
similar structures have been reported with other RIPs. Trichosanthin (TCS), a type-I RIP 
purified from Trichosanthes kirilowii maxim, comprises of α-helices, β-sheets, random coils 


















The secondary structure of rBalsamin was found to be stable in the temperature range of 
20-60 °C as little or no change in the CD spectrum was observed within this temperature range. 
However, above 60 °C, a slight distortion was observed in the secondary structure indicating 
that rBalsamin is unstable at high temperatures (Fig. 6A). Also, the effect of pH on the 
secondary structure of rBalsamin was studied to determine the stability of the protein. 
rBalsamin was stable as no spectral variations were noted between pH 6-11. However, below 
pH 6, a slight disruption in the CD spectra was observed indicating that rBalsamin is unstable 
under acidic conditions (Fig. 6B).  
Temperature and pH-dependence effects on the fluorescence emission spectra of 
rBalsamin were studied using fluorescence spectroscopy. rBalsamin was found to be stable in 
the temperature range of 20-60 °C as no shift in the emission peak was observed within this 
temperature range. However, above 60 °C, a decrease in the fluorescence intensity with a shift 
in emission peak was observed, indicating that rBalsamin is unstable at higher temperatures 
(Fig. 7A). The fluorescence scans in the pH range of 4 to 11 demonstrated that rBalsamin is 
stable in a pH range of 6 to 9 as no shift in the emission peak was observed within this range. 
However, an increase in the fluorescence intensity below pH 6 and decrease in the fluorescence 
intensity above pH 9 with a shift in the emission peak towards higher wavelength suggested 
that rBalsamin is unstable at pH below 6 and above 9 (Fig. 7B). 
3.5  DNase-like activity of rBalsamin 
To optimize rBalsamin concentration for DNase-like activity, pUC19 plasmid was used as 
a substrate. Treatment of supercoiled pUC19 with various concentrations of rBalsamin (0.5-2 
μg) resulted in conversion of supercoiled plasmid into the open circular and linear forms (Fig. 
8). 0.5 and 1 μg of rBalsamin treatment partially converted the supercoiled form into the open 
circular form. However, when the concentration of rBalsamin was increased to 1.5 μg, almost 
complete disappearance of supercoiled plasmid was observed with the appearance of the linear 
form of the DNA. At a concentration of 2 μg, rBalsamin completely converted supercoiled and 
open circular forms of DNA to the linear form, suggesting that 2 μg of rBalsamin is the 
optimum concentration for DNase-like activity (Fig. 8). These results were in accordance with 
DNase-like activity of other RIPs reported from different plant species [29] and nBalsamin 


















3.6  Antimicrobial activity of rBalsamin 
RIPs have been classified as defense proteins, which could function as antimicrobial agents 
[30]. ME1 and ME2, two type I RIPs, from Mirabilis expansa roots exhibited strong inhibitory 
activity against an array of fungal pathogens including Fusarium and Trichoderma species 
[31]. Similarly, α-MMC from M. charantia demonstrated growth inhibitory effect against 
various bacterial and fungal pathogens such as Fusarium species, E. coli, P. aeruginosa, S. 
aureus and Bacillus subtilis [13]. In this study, disc diffusion method was performed to 
determine the zone of inhibition of different dilutions of rBalsamin on various pathogenic 
microorganisms. The assay demonstrated that rBalsamin inhibited the growth of pathogens in 
a dose dependent manner with maximum inhibitory effect observed at the highest dose. 
rBalsamin was found to be highly effective against S. epidermidis, S. aureus, S. enterica and 
E. coli and comparatively less effective against P. aeruginosa and E. faecalis (Fig. S6). The 
zone of inhibition caused by different dilutions of rBalsamin on the various pathogens ranged 
between 2.2-9.0 mm (Table 2). 
Further, the minimum inhibitory concentrations (MIC’s) of rBalsamin were determined by 
the broth microdilution method. The MIC’s of rBalsamin were found to be in the following 
order: S. epidermidis < S. aureus < S. enterica = E. coli < P. aeruginosa = E. faecalis (Fig. 
S7, Table 3) suggesting that rBalsamin exhibits growth inhibitory activity towards various 
pathogens that could prove beneficial in plant protection. 
3.7  Antioxidant activity of rBalsamin 
DPPH (2,2-diphenyl-1-picrylhydrazyl) is a free radical that is widely used to monitor chemical 
reactions involving free radicals [32-34]. DPPH has a violet colour in the solution with a 
characteristic absorption at 517 nm. In presence of an antioxidant molecule, it gets reduced and 
becomes colourless or pale yellow. However, in our study, rBalsamin concentration did not 
affect free radical scavenging of DPPH as no DPPH reduction was observed (Fig. S8A). 
The superoxide radical scavenging assay is based on the capacity of the protein to inhibit 
the photochemical reduction of nitroblue tetrazolium (NBT) [35]. However, in our study, it 
was observed that rBalsamin did not exhibit this activity as no NBT reduction was observed 
with different concentrations of rBalsamin (Fig. S8B).  
Reducing power measures the total antioxidant ability of a compound and the efficiency 
of an antioxidant to donate electrons. The reducing ability of the compound ferricyanide 

















assay showed that the reducing power ability tended to increase as the concentration of 
rBalsamin increased. However, none of these results were statistically significant 
demonstrating that the protein does not possess reducing ability (Fig. S8C).  
4. Conclusion 
In this study, we discussed the development of a two-step purification procedure for the 
production of functionally bioactive balsamin from M. balsamina. Optimization of expression 
parameters such as induction time, IPTG concentration and temperature led to maximum 
protein yield after 4 h of 0.4 mM IPTG induction at 30 °C in the E.coli BL21(DE3) expression 
system. The incorporation of a His-tag on the N-terminus of the protein allowed purification 
of rBalsamin by Ni2+ Sepharose affinity chromatography. Functional analysis indicated that 
rBalsamin exhibited RNA N-glycosidase, DNase-like and antimicrobial activity in a 
concentration-dependent manner. The structure of rBalsamin was found to be sensitive to 
higher temperatures, and a highly acidic or basic environment. Heterologous expression of 
rBalsamin using E.coli system not only provides an alternative approach for large-scale 
production and purification of rBalsamin, which would enable further structural and functional 
studies and detailed investigation on the mechanism of DNase-like and antimicrobial activities 
of balsamin, but also a versatile approach for genetic manipulation in the rational development 
of this potential therapeutic agent. 
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Legend to Figures: 
Fig. 1 SDS-PAGE analysis of expression of rBalsamin in E.coli. 
Fig. 2 Optimization of expression of rBalsamin in E.coli. 



















Table 1 Degenerate primers used for balsamin gene amplification. 
Gene Primer sequence 
MAP 
Forward primer: 5’-CATGCGGGATCCATGGTGAAATGCTTAC-3’ 
Reverse primer: 5’-CGAGCCTCGAGTCAATTCACAACAG-3’ 
Gel 
Forward primer: 5’-CATGCGGGATCCACYTGRTCNACNGCNGTNACRTARTAYTTYTT-3’ 
Reverse primer: 5’-CGAGCCTCGAGTTYAARGAYGCNCCNGAYGCNGCNTAYGARGG-3’ 
Sap 
Forward primer: 5’-CATGCGGGATCCCTGCAGAATTCGCATGGATCCTGCAAT-3’ 
Reverse primer: 5’-CGAGCCTCGAGCTGCAGAATTCGCCTCGTTTGACTACTTTG-3’ 
Luf 
Forward primer: 5’-CATGCGGGATCCCAGATGTGAGGTTCAGTTTGTCAGGT-3’ 
Reverse primer: 5’-CGAGCCTCGAGCGCAACATTTTGTTTGTA-3’ 
PAP 
Forward primer: 5’-CATGCGTCCCTTCAGCTGATAAATACGATCACCTTTGATC-3’ 
Reverse primer: 5’-CGAGCCTCGAGCGGGATCCGAATCCTTCAAATAGATCAC-3’ 
Mom 
Forward primer: 5’-CATGCGGGATCCGATGTTAGCTTTCGTTTG-3’ 
Reverse primer: 5’-CGAGCCTCGAGTTAGGGCATTCTAGTAGCTC-3’ 
PAPII 
Forward primer: 5’-CATGCGGGATCCATRTAYTTRAATCTIGCIGCYT-3’ 
Reverse primer: 5’-CGAGCCTCGAGTGAAYATHGTITTYGAYGTIGARAA-3’ 
MAP: Momordica antiviral protein; gel: gelonin; sap: saporin; Luf: α-luffin; PAP: pokeweed 

















Table 2 Antibacterial activity of rBalsamin towards different pathogenic microorganisms.  
Microorganisms 
Zone of inhibition in mm ± SD 
rBalsamin concentration (μg/ml) 
50 100 200 
Staphylococcus aureus 3.1 ± 0.2 6.2 ± 0.5 8.0 ± 0.4 
Pseudomonas aeruginosa ND 2.2 ± 0.3 5.1 ± 0.7 
Escherichia coli 2.2 ± 0.1 4.4 ± 0.3 6.3 ± 0.5 
Staphylococcus epidermidis 4.1 ± 0.3 6.2 ± 0.4 9.0 ± 0.7 
Salmonella enterica 2.7 ± 0.2 5.5 ± 0.6 7.1 ± 0.5 
Enterococcus faecalis ND ND 3.3 ± 0.2 



















Table 3 Minimum inhibitory concentrations (MICs) of rBalsamin against different pathogenic 
microorganisms. 
 
Microorganisms MICs of rBalsamin (µg/ml) 
Staphylococcus aureus 6.25 
Pseudomonas aeruginosa 25.00 
Escherichia coli 12.50 
Staphylococcus epidermidis 1.56 
Salmonella enterica 12.50 




















 Balsamin was cloned and expressed in E.coli BL21 (DE3) strain, and purified by two-step 
purification 
 Recombinant Balsamin exhibited RNA N-glycosidase and DNase-like activity. 
 rBalsamin consisted of α-helical and random coiled with minimal turns and β-sheets. 
 Structure of rBalsamin was found to be sensitive to higher temperatures, acidic/ basic 
environment. 
 Antimicrobial assay revealed that rBalsamin inhibited the growth of various bacterial 
pathogens in a dose dependent manner  
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